1

Is this a robust study and are the conclusions supported by the data?

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417612/

Emphasis is mine.

Two doses (300 μg/kg/dose in a gap of 72 hours) of ivermectin chemoprophylaxis reduced COVID-19 infection by 83% among HCWs for one month. Ivermectin is a safe and effective strategy to prevent COVID-19, in the containment of pandemic alongside vaccine. Further research is required to guide the frequency of chemoprevention, acceptability, and cost-effectiveness in the community setting.

3
  • 1
    Did you mean to post this on Skeptics? Either way, please take our tour and refer to the help center for guidance about our ways as and when. Welcome to the network. Jan 31, 2022 at 17:32
  • Think about aspects of a clinical trial that should be there (but aren't in this paper) to show some effect. Also check out the Kaplan-Meyer plot (2'nd to last fig?)...interesting. Also, ivermectin does work in the lab, just at concs well above what you can achieve in the body.
    – bob1
    Jan 31, 2022 at 19:40
  • 3
    I’m voting to close this question because it belongs on skeptics and is crossposted there.
    – JohnP
    Feb 1, 2022 at 15:50

0

Browse other questions tagged or ask your own question.